eScholarship
metadata only
Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process
Mutations in the isocitrate dehydrogenase gene IDH1 are common in low-grade glioma, where they result in the production of 2-hydroxyglutarate (2HG), disrupted patterns of histone methylation, and gliomagenesis. IDH1 mutations also cosegregate with mutations in the ATRX gene and the TERT promoter, su
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- IDH1/2 (isocitrate dehydrogenase 1/2) Mutations in Gliomas : genotype-Phenotype Correlation, Prognostic impact, and Response to Irradiation#445553
- Molecular Pathology Research Project of Glioma#803250
- DNA Methylation Profiling in IDH-Mutant Gliomas: Biological Evolution, Molecular Grading and Clinical Implementation.#480877
- Image 5_HIST1H2BJ is associated with poor prognosis and an immune-altered tumor microenvironment in glioma.pdf#922327
- Image 1_HIST1H2BJ is associated with poor prognosis and an immune-altered tumor microenvironment in glioma.jpeg#922330
Record · ID 1263537
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive